360 NEWS360 NEWS
Home / Business

Vanguards of Healthcare: ProFound Uses AI to Map the Dark Genome

“There’s no doubt it’s uniquely enabling us to see relationships, pathways, interactions, risks that we couldn’t have seen just by sort of human scouring of data.” ProFound Therapeutics CEO John Lepore tells Bloomberg Intelligence, highlighting the potential to uncover an entirely new set of disease...

Published
Original News Source Bloomberg — Business
Content & Media Rights Inigo Imaz Blanco / Bloomberg — Business
Editorial Publisher 360 NEWS (Independent Media)
“There’s no doubt it’s uniquely enabling us to see relationships, pathways, interactions, risks that we couldn’t have seen just by sort of human scouring of data.” ProFound Therapeutics CEO John Lepore tells Bloomberg Intelligence, highlighting the potential to uncover an entirely new set of disease targets beyond the proteins traditionally recognized by science. In this Vanguards of Healthcare podcast episode, Lepore sits down with BI Senior Pharmaceuticals Analyst Sam Fazeli for an in-depth in

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].